Terumo Acquires 5% Of Fuji Pharma To Grow Drug/Device Combo Product Business
This article was originally published in The Pink Sheet Daily
Executive Summary
Partners hope to capitalize on reform that narrows approval of pre-filled syringes to a single agency.